Signature Equity Partners’s Axcelis ACLS Stock Holding History

Signature Equity Partners’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$1.61K	–	1551
2025 Q4	$1.61K	Buy	+20	New	+$1.68K	﹤0.01%	1277

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Signature Equity Partners's ACLS Position: Q1 2026 in Review

Signature Equity Partners sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 20 shares — an estimated $1.61K sold.

Signature Equity Partners first reported a position in ACLS in Q4 2025 and held it in 1 quarter. The position peaked at $1.61K in Q4 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

Signature Equity Partners reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
Signature Equity Partners sold 20 Axcelis shares in Q1 2026, an estimated $1.61K.
Signature Equity Partners first reported a position in Axcelis in Q4 2025 and held it in 1 quarter.
Signature Equity Partners's Axcelis position peaked at $1.61K in Q4 2025.
377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.